Mahesh Karande - 29 Jul 2021 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Barbara Chan as Attorney-in-fact for Mahesh Karande
Issuer symbol
OMGAQ
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 21:02:09 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMGA Common Stock 106,411 29 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMGA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 895,371 $0.5300 Direct F1
holding OMGA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 326,382 $0.6000 Direct F1
holding OMGA Stock Option (Right to Buy) 29 Jul 2021 Common Stock 937,588 $5.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on April 1, 2020 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on April 1, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2 The options vest and become exercisable with respect to 25% of the underlying shares on March 26, 2022 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 26, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney.